BioLamina AB develops, manufactures and markets cell culture reagents intended for culturing of primary cells. Its applications animal stem cells, cancer cells, cardiac applications, clonal applications, endothelial applications, epithelial applications, expansion of human PSC, eye applications, hepatic applications, intestinal applications, kidney cell culture, lung applications, neural applications, pancreatic applications and skeletal muscle applications. The company was founded by Kristian Tryggvason and Karl Tryggvason in 2008 and is headquartered in Sundbyberg, Sweden.

Hoechst AG produced specialty chemicals and pharmaceutical products. It products ranged in areas of heart cycle, thrombose, central nervous system, onkologie, diabetes, metabolic illnesses, internal medicine and vaccines. Founded in 1863, the company was headquartered in Frankfurt am Main, Germany.

immatics is a biopharmaceutical company focused on the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors. The company's customized Adoptive Cell Therapies (ACTengine) and antibody-like TCR Bispecifics are the two main product classes in the pipeline (TCER). With a focus on particularly difficult-to-treat solid malignancies, each therapy modality has unique characteristics to create the desired therapeutic impact for patients at various disease stages and with various types of tumors. immatics biotechnologies was established in 2000 by Hans Rammensee, Harpreet Singh, and Steffen Walter in Tübingen, Baden-Wurttemberg.

Ramot at Tel Aviv University Ltd. operates as a technology transfer company of Tel Aviv University (TAU). It provides legal and commercial frameworks for inventions made by TAU faculty, students, and researchers. The firm licenses the university's intellectual property to third parties through agreements; facilitates collaborative research partnerships between business partners and TAU researchers; establishes a company; and forms joint ventures that promote TAU technologies. The company was founded in 1973 and is headquartered in Tel Aviv, Israel.

Quantum Immunologics, Inc., a biotechnology company, engages in the research, development, and production of immunologic treatment systems for breast cancer. Its products include individualized cancer immunotherapy system, a system in which blood drawn from a patient is treated with a process and cells are injected back into the patient; cancer monitoring test that uses cancer immunotherapy to monitor blood levels of the immune response in a patient following treatment; and cancer screening test, a blood test. The company is based in Tampa, Florida.

Manufactures pharmaceuticals

Sanofi is a global healthcare company. Among their duties are researching disease causes, determining starting points for drug treatment, developing drugs, producing active ingredients, and delivering finished drugs and active ingredients. Specialists in vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare.

ChondroNest is developing the application of this intellectual property for the reconstruction of Hyaline cartilage. They are aiming to conduct preclinical tests on animal models for two indications, the Osteochondritis and subsequently the Osteoarthrosis. After the first in-man preclinical trials the product will be licensed to major MedTech companies for sales and marketing while they will retain the production of ChondroNest™ pastes.

Hexie Technology Co., Ltd., established on 2017-10-24, Business scope includes technical services,technology transfer,technology development,Technology Promotion,technical consulting;Natural science research and experimental development;Medical Research and Experimental Development;Engineering and Technology Research and Experimental Development;software development;Computer System Services;data processing(Bank Card Center in Data Processing,PUEvalue in1.5Except for the above cloud computing data centers);market survey;Business Management Consulting;Economic and Trade Consulting;health management(Except for medical treatment activities subject to approval);Health Advisory(Except for medical treatment activities subject to approval);Sales of chemical reagents,Class Ι medical device,IIkind,cosmetic,sporting goods,Fitness Equipment;Production No.Iclass of medical devices;Technology intermediary service;Import and export;Agent import and export;Technology Import and Export;trade agent;sell food;Sales No.IIIclass of medical devices;Production No.IIkind,No.IIIclass of medical devices.(Market entities independently choose business projects in accordance with the law,Carry out business activities;sell food,Production No.IIkind,No.IIIclass of medical devices,Sales No.IIIClass medical devices and items subject to approval according to law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Senju Pharmaceutical Beijing Co. Ltd., part of Senju Pharmaceutical Co., Ltd., is a company headquartered in Beijing, China, that manufactures and distributes pharmaceuticals.

Arrogene is a developer of a cancer medical technology designed to create a new generation of nano agents capable of delivering peptide, protein, and oligonucleotide therapeutics across the blood-brain barrier. The company's technology offers a unique nano-medicine platform that delivers multiple tumor inhibitors or imaging agents and is being tailored to fight different types of cancer, enabling patients to prevent tumor growth for imaging.

Sanofi A/S engages in the production of prescription drugs as well as participates in clinical trials of present and future products. It specializes in diabetes, oncology, multiple sclerosis, rare disease and cardio vascular illnesses. The company is headquartered in Copenhagen, Denmark.

TEDA International Cardiovascular Hospital (Chinese: 泰达国际心血管病医院) is a specialist cardiovascular hospital in the Binhai New Area of Tianjin, China.

Accurate International is engaged in the research and development of regenerative medicines based on the four centers of organoid tissue and disease models. clinical medicine transformation, big data sharing, and smart device development.

Shanghai Zhuoruan Medical Technology Co., Ltd., established on 2015-07-20, Business scope includes medical technology,Material Technology,Technology development in the field of biotechnology specialization,technical consulting,Technical Services,technology transfer(GMOs,Except human stem cell genetic diagnosis),Class I medical device,chemical reagent(except medical,Diagnostic reagents),Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals)promotion of.[Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]